{"filing": {"accession": "0001477932-26-003159", "cik": "0001443863", "ticker": "BICX", "company_name": "BioCorRx Inc.", "form_type": "10-Q", "filing_type": "10-Q", "filing_date": "2026-05-15", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1443863/000147793226003159/0001477932-26-003159-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1443863/000147793226003159/0001477932-26-003159-index.htm", "period_of_report": "2026-03-31"}, "html_url": "/api/filings/000147793226003159/stream", "exhibits": [], "sections": [{"section_name": "item_1a", "section_title": "Risk Factors", "start_position": 3389, "end_position": 3519}, {"section_name": "item_4", "section_title": "Mine Safety Disclosures", "start_position": 3519, "end_position": 5853}, {"section_name": "part_1", "section_title": "Part I", "start_position": 5853, "end_position": 161296}, {"section_name": "part_2", "section_title": "Part II", "start_position": 161296, "end_position": 166997}], "tables": [{"table_index": 4, "table_type": "text", "caption": null, "header_text": "Nevada90-0967447"}, {"table_index": 5, "table_type": "text", "caption": null, "header_text": "Title of each classTrading Symbol(s)Name of each exchangeon which registered"}, {"table_index": 6, "table_type": "text", "caption": null, "header_text": "Large accelerated filer\u2610Accelerated filer\u2610"}, {"table_index": 9, "table_type": "financial", "caption": null, "header_text": "PART I. FINANCIAL INFORMATION"}, {"table_index": 13, "table_type": "financial", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 16, "table_type": "financial", "caption": null, "header_text": "Three months ended"}, {"table_index": 19, "table_type": "text", "caption": null, "header_text": "Series ASeries B"}, {"table_index": 22, "table_type": "text", "caption": null, "header_text": "Series ASeries B"}, {"table_index": 25, "table_type": "financial", "caption": null, "header_text": "Three Months ended"}, {"table_index": 28, "table_type": "financial", "caption": null, "header_text": "\u00b7Unsatisfied Performance Obligations - all performance obligations relate to contracts with a duration of less than one year. The Company has elected to apply the optional exemption provided in ASC 60"}, {"table_index": 30, "table_type": "text", "caption": null, "header_text": "Three Months EndedMarch 31,"}, {"table_index": 32, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 33, "table_type": "financial", "caption": null, "header_text": "Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficie"}, {"table_index": 36, "table_type": "text", "caption": null, "header_text": "Three Months Ended"}, {"table_index": 41, "table_type": "financial", "caption": null, "header_text": "Fair value of consideration transferred:"}, {"table_index": 42, "table_type": "text", "caption": null, "header_text": "Risk-free interest rate3.96%"}, {"table_index": 44, "table_type": "text", "caption": null, "header_text": "Fair ValueEstimated useful life"}, {"table_index": 45, "table_type": "financial", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 46, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 48, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 49, "table_type": "text", "caption": null, "header_text": "Total"}, {"table_index": 50, "table_type": "financial", "caption": null, "header_text": "Three Months Ended"}, {"table_index": 51, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 53, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 54, "table_type": "text", "caption": null, "header_text": "YearAmount"}, {"table_index": 56, "table_type": "financial", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 60, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 62, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 64, "table_type": "text", "caption": null, "header_text": "YearAmount"}, {"table_index": 67, "table_type": "text", "caption": null, "header_text": "Weighted-"}, {"table_index": 69, "table_type": "text", "caption": null, "header_text": "Options OutstandingOptions Exercisable"}, {"table_index": 71, "table_type": "text", "caption": null, "header_text": "Warrants OutstandingWarrants Exercisable"}, {"table_index": 73, "table_type": "text", "caption": null, "header_text": "Weighted"}, {"table_index": 75, "table_type": "text", "caption": null, "header_text": "BioCorRxPharmaceuticals,Inc.JosephDeSantoMD"}, {"table_index": 76, "table_type": "text", "caption": null, "header_text": "BioCorRxPharmaceuticals,Inc.JosephDeSantoMD"}, {"table_index": 77, "table_type": "text", "caption": null, "header_text": "Balance, December 31, 2025$(303,429)"}, {"table_index": 78, "table_type": "text", "caption": null, "header_text": "Balance, December 31, 2024$(234,812)"}, {"table_index": 82, "table_type": "text", "caption": null, "header_text": "March 31,December 31,"}, {"table_index": 83, "table_type": "text", "caption": null, "header_text": "For the Three Months Ended March 31, 2026For the Three Months Ended March 31, 2025"}, {"table_index": 85, "table_type": "text", "caption": null, "header_text": "Upfront Purchase PriceRoyalty Payment"}, {"table_index": 86, "table_type": "text", "caption": null, "header_text": "Upfront Purchase PriceRoyalty Payment"}, {"table_index": 90, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 93, "table_type": "text", "caption": null, "header_text": "20262025"}, {"table_index": 101, "table_type": "exhibit_index", "caption": null, "header_text": "10.1Form of Stock Exchange Agreement, dated March 26, 2026 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 2, 2026)."}, {"table_index": 102, "table_type": "exhibit_index", "caption": null, "header_text": "**Filed herewith."}, {"table_index": 104, "table_type": "text", "caption": null, "header_text": "BIOCORRX INC."}], "exhibits_pending": true, "cdn_html": true, "response_time_ms": 82}